168 related articles for article (PubMed ID: 32812439)
1. Unleash multifunctional role of long noncoding RNAs biomarker panel in breast cancer: a predictor classification model.
Toraih EA; El-Wazir A; Ageeli EA; Hussein MH; Eltoukhy MM; Killackey MT; Kandil E; Fawzy MS
Epigenomics; 2020 Jul; 12(14):1215-1237. PubMed ID: 32812439
[No Abstract] [Full Text] [Related]
2. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.
Han L; Ma P; Liu SM; Zhou X
Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314
[TBL] [Abstract][Full Text] [Related]
3. Serum Long Non-Coding RNAs PVT1, HOTAIR, and NEAT1 as Potential Biomarkers in Egyptian Women with Breast Cancer.
El-Fattah AAA; Sadik NAH; Shaker OG; Mohamed Kamal A; Shahin NN
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670447
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNAs as novel prognostic biomarkers for breast cancer in Egyptian women.
El-Helkan B; Emam M; Mohanad M; Fathy S; Zekri AR; Ahmed OS
Sci Rep; 2022 Nov; 12(1):19498. PubMed ID: 36376369
[TBL] [Abstract][Full Text] [Related]
5. Circulating LncRNAs landscape as potential biomarkers in breast cancer.
Pourramezan Z; Attar FA; Yusefpour M; Azizi M; Oloomi M
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1722. PubMed ID: 36274054
[TBL] [Abstract][Full Text] [Related]
6. lncRNAs in Non-Malignant Tissue Have Prognostic Value in Colorectal Cancer.
Thiele JA; Hosek P; Kralovcova E; Ostasov P; Liska V; Bruha J; Vycital O; Rosendorf J; Opattova A; Horak J; Kralickova M; Vodicka P; Pitule P
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205577
[TBL] [Abstract][Full Text] [Related]
7. Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer.
Özgür E; Ferhatoğlu F; Şen F; Saip P; Gezer U
Cancer Biomark; 2020; 27(1):11-17. PubMed ID: 31640083
[TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
9. Expression levels of breast cancer-related GAS5 and LSINCT5 lncRNAs in cancer-free breast tissue: Molecular associations with age at menarche and obesity.
Mansoori Y; Tabei MB; Askari A; Izadi P; Daraei A; Bastami M; Naghizadeh MM; Nariman-Saleh-Fam Z; Mansoori B; Tavakkoly-Bazzaz J
Breast J; 2018 Nov; 24(6):876-882. PubMed ID: 29785740
[TBL] [Abstract][Full Text] [Related]
10. A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.
Tang Y; Wang Y; Wang X; Liu Y; Zheng K
Clin Breast Cancer; 2019 Jun; 19(3):e415-e421. PubMed ID: 30846409
[TBL] [Abstract][Full Text] [Related]
11. Gene Expression of the Circulating Long Noncoding RNA
Ismail DM; Shaker OG; Kandeil MA; Hussein RM
Genet Test Mol Biomarkers; 2019 Sep; 23(9):671-680. PubMed ID: 31433231
[No Abstract] [Full Text] [Related]
12. Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer.
Kong H; Wu Y; Zhu M; Zhai C; Qian J; Gao X; Wang S; Hou Y; Lu S; Zhu H
Oncotarget; 2016 Aug; 7(31):50428-50436. PubMed ID: 27391432
[TBL] [Abstract][Full Text] [Related]
13. Circulating long non-coding RNA MALAT1 expression as molecular biomarker in Egyptian patients with breast cancer.
Zidan HE; Karam RA; El-Seifi OS; Abd Elrahman TM
Cancer Genet; 2018 Jan; 220():32-37. PubMed ID: 29310836
[TBL] [Abstract][Full Text] [Related]
14. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
15. Expression and Clinicopathological Significances of lncRNAs: Could ARA and ZEB2NAT be the Potential Breast Cancer-Related Biomarkers?
Hesami S; Sayar M; Sayyar F; Eshaghkhani Y; Pirhoushiaran M; Khadem Erfan MB; Abdollahzadeh R; Azarnezhad A
Arch Med Res; 2020 Nov; 51(8):851-859. PubMed ID: 32921528
[TBL] [Abstract][Full Text] [Related]
16. Dual biomarkers long non-coding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors.
Toraih EA; Alghamdi SA; El-Wazir A; Hosny MM; Hussein MH; Khashana MS; Fawzy MS
PLoS One; 2018; 13(10):e0198231. PubMed ID: 30289954
[TBL] [Abstract][Full Text] [Related]
17. Investigating the diagnostic performance of HOTTIP, PVT1, and UCA1 long noncoding RNAs as a predictive panel for the screening of colorectal cancer patients with lymph node metastasis.
Gharib E; Anaraki F; Baghdar K; Ghavidel P; Sadeghi H; Nasrabadi PN; Peyravian N; Aghdaei HA; Zali MR; Mojarad EN
J Cell Biochem; 2019 Sep; 120(9):14780-14790. PubMed ID: 30993787
[TBL] [Abstract][Full Text] [Related]
18. The lncRNAs Gas5, MALAT1 and SNHG8 as diagnostic biomarkers for epithelial malignant pleural mesothelioma in Egyptian patients.
Elkahwagy DM; Kiriacos CJ; Sobeih ME; Khorshid OMR; Mansour M
Sci Rep; 2024 Feb; 14(1):4823. PubMed ID: 38413635
[TBL] [Abstract][Full Text] [Related]
19. Association of MALAT1 and PVT1 Variants, Expression Profiles and Target miRNA-101 and miRNA-186 with Colorectal Cancer: Correlation with Epithelial-Mesenchymal Transition.
Radwan AF; Shaker OG; El-Boghdady NA; Senousy MA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200314
[TBL] [Abstract][Full Text] [Related]
20. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.
Malih S; Saidijam M; Malih N
Tumour Biol; 2016 Feb; 37(2):1479-85. PubMed ID: 26662315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
